More News! 10 Oct 2022RadioMedix announces a $40 million series A financing for targeted alpha therapy platform A company committed to advancing treatments for rare and aggressive cancers has received a series A funding of $40 million.… October 10, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email